Curis (CRIS) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free CRIS Stock Alerts $14.47 -0.05 (-0.34%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCuris (NASDAQ:CRIS) Shares Cross Above Two Hundred Day Moving Average of $10.29americanbankingnews.com - April 25 at 3:14 AMCuris, Inc. (CRIS)finance.yahoo.com - April 23 at 11:18 PMCuris, Inc. (CRIS) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - April 18 at 11:37 PMCuris (NASDAQ:CRIS) Share Price Crosses Above 200-Day Moving Average of $10.73americanbankingnews.com - April 17 at 3:00 AMCuris (NASDAQ:CRIS) Stock Passes Above Two Hundred Day Moving Average of $10.49marketbeat.com - April 9 at 2:53 AMCuris Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)prnewswire.com - April 5 at 7:30 AMCuris to Present at Upcoming Healthcare Conferences in Aprilprnewswire.com - April 4 at 7:30 AMSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS)prnewswire.com - April 2 at 9:15 AMCuris, Inc. (NASDAQ:CRIS) Sees Large Drop in Short Interestmarketbeat.com - March 30 at 10:27 PMCuris, Inc. (CRIS) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - March 28 at 10:01 PMCitigroup Inc. Sells 1,745,553 Shares of Curis, Inc. (NASDAQ:CRIS)marketbeat.com - March 22 at 4:34 AMCuris (NASDAQ:CRIS) Shares Cross Above Two Hundred Day Moving Average of $10.26marketbeat.com - March 21 at 3:09 AMKingdon Capital Management L.L.C. Sells 2,215,274 Shares of Curis, Inc. (NASDAQ:CRIS)marketbeat.com - March 5 at 3:25 PMCuris, Inc. (NASDAQ:CRIS) Shares Sold by Citigroup Inc.marketbeat.com - March 4 at 4:34 AMCuris Stock (NASDAQ:CRIS) Dividends: History, Yield and Datesbenzinga.com - February 24 at 9:47 AMCuris Stock (NASDAQ:CRIS), Analyst Ratings, Price Targets, Predictionsbenzinga.com - February 22 at 7:00 AMBleichroeder LP Has $165,000 Holdings in Curis, Inc. (NASDAQ:CRIS)marketbeat.com - February 12 at 11:39 AMCuris Inc. Is Worried About This – Should You Be Worried Too?msn.com - February 10 at 9:57 AMCuris, Inc. (NASDAQ:CRIS) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 9 at 2:08 PMCuris (NASDAQ:CRIS) Issues Earnings Results, Misses Expectations By $0.12 EPSmarketbeat.com - February 9 at 1:39 PMCuris, Inc.: Curis Provides Fourth Quarter 2023 Business Updatefinanznachrichten.de - February 8 at 6:13 PMCuris Inc Q4 sales declinemarkets.businessinsider.com - February 8 at 6:13 PMCuris Provides Fourth Quarter 2023 Business Updatefinance.yahoo.com - February 8 at 8:13 AMCuris's Earnings: A Previewbenzinga.com - February 7 at 8:45 PMCuris (CRIS) to Release Earnings on Thursdaymarketbeat.com - February 2 at 9:35 AMCuris to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024finance.yahoo.com - February 1 at 10:00 AMCuris Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)finance.yahoo.com - January 22 at 2:28 PMCuris, Inc. (NASDAQ:CRIS) Surges 54% Yet Its Low P/S Is No Reason For Excitementfinance.yahoo.com - December 18 at 11:15 AMBuy Rating on Curis Backed by Promising Clinical Trials and Strategic Expansionmarkets.businessinsider.com - December 12 at 8:42 AMCuris Announces Initial Combination Study Data from its TakeAim Lymphoma Studyfinance.yahoo.com - December 12 at 8:42 AMCuris Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conferencefinance.yahoo.com - December 11 at 9:05 AMPositive Buy Rating for Curis Stock Driven by Emavusertib’s Clinical Promise and Revenue Potentialmarkets.businessinsider.com - December 6 at 9:54 AMCuris Announces Three Presentations at ASHfinance.yahoo.com - December 6 at 9:54 AMCuris Inks Deal With Florida University For Emavusertib/Pembrolizumab Combination Study In Melanomamarkets.businessinsider.com - December 5 at 1:04 PMCuris Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanomafinance.yahoo.com - December 5 at 1:04 PMCuris Inc CRISmorningstar.com - November 18 at 3:23 PMTruist Securities Initiates Coverage of Curis (CRIS) with Buy Recommendationmsn.com - November 18 at 10:23 AMCuris, Emergent Biosolutions among healthcare moversmsn.com - November 17 at 1:00 PMCuris’s stock rises as analysts see ‘the next Pharmacyclics’msn.com - November 17 at 1:00 PMmarketbeat.com - November 17 at 10:45 AMmarketbeat.com - November 17 at 10:32 AMmarketbeat.com - November 17 at 10:25 AMmarketbeat.com - November 17 at 9:55 AMCuris, Inc. (NASDAQ:CRIS) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 3 at 3:15 PMAnalysts Conflicted on These Healthcare Names: Curis (CRIS), Trevi Therapeutics (TRVI) and Prothena (PRTA)markets.businessinsider.com - November 3 at 10:15 AMCuris Inc (CRIS) Reports Q3 2023 Financial Results: Net Loss Decreases Year-Over-Yearfinance.yahoo.com - November 3 at 10:15 AMCuris Inc Q3 Loss decreases, beats estimatesmarkets.businessinsider.com - November 2 at 1:15 PMCuris Provides Third Quarter 2023 Business Updatefinance.yahoo.com - November 2 at 8:15 AMPreview: Curis's Earningsbenzinga.com - November 1 at 8:15 PMCuris to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023finance.yahoo.com - October 26 at 1:05 PM Get Curis News Delivered to You Automatically Sign up to receive the latest news and ratings for CRIS and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. CRIS Media Mentions By Week CRIS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRIS News Sentiment▼-0.140.33▲Average Medical News Sentiment CRIS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRIS Articles This Week▼31▲CRIS Articles Average Week Get Curis News Delivered to You Automatically Sign up to receive the latest news and ratings for CRIS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sangamo Therapeutics News Today Agenus News Today Precision BioSciences News Today AlloVir News Today Protalix BioTherapeutics News Today CEL-SCI News Today Atara Biotherapeutics News Today Athira Pharma News Today Passage Bio News Today Gritstone bio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRIS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
